As lung cancer remains the number one cause of cancer deaths worldwide, the need to continuously assess the impact of our therapeutic options remains a high priority across all disciplines involved in the care of these patients. The thoracic session of the conference will cover many of the new guidelines, treatment options, and therapeutic discussions occurring worldwide in the management of the patient with NSCLC (non-small cell lung cancer). Some of the topics covered in the conference include tobacco cessation, diagnosing and managing lung cancer in former smokers, molecular testing, immunotherapy, treating the patient with ALK+ adenocarcinoma, and assessing for complications resulting from new therapies. There will be an update on the management of patients with relapsed small cell lung cancer, discussion of robotic surgery in the management of thoracic cancers, and guidelines for managing the patient with ground glass opacities (GGO’s).

Gastrointestinal cancers encompass a wide range of organ systems from the esophagus to the rectum including hepatobiliary and pancreas. The purpose of the GI session is to improve cancer care for patients throughout these systems. This year’s conference will focus on changes in the National Comprehensive Cancer Network (NCCN) guidelines for gastric, pancreas, colon, and liver cancer as well as introduce nonclinical barriers such as health literacy and caregiver stress. Finally, the conference will strive to simplify genetic testing from the perspective of a geneticist and pathologist.

TARGET AUDIENCE
Physicians
Radiation Oncologists
Nurse Practitioners
Physician Assistants
Nurses
Residents
Respiratory Therapists

OBJECTIVES
As a result of attending this course, participants will be able to:

Thoracic Session

• Review current guidelines for tobacco cessation and molecular testing in patients with NSCLC
• Discuss evidence-based, multidisciplinary management of patients with various types of lung cancer
• Discuss latest advances in immunotherapy for lung cancer
• Review current perspectives in radiation therapy and robotic thoracic surgery

GI

• Explain recent changes in the NCCN guidelines for esophageal/gastroesophageal junction (GEJ), pancreas and colorectal cancers
• Recognize when and which molecular studies should be ordered and their relevance
• Define health literacy and its potential barrier to patient care
• Describe the effect of caregiver stress to patients’ care.

CME INFORMATION

PHYSICIANS
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Thoracic
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

GI
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Full Conference
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES
Nebraska Medicine is an approved provider of continuing nursing education by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

For more information or to register:
https://www.unmc.edu/cce/catalog/clinicmed/thoracic-gi/index.html